These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


377 related items for PubMed ID: 10167120

  • 1. Networks can avoid antitrust scrutiny.
    Waxman JM.
    Provider; 1997 Feb; 23(2):42-5. PubMed ID: 10167120
    [No Abstract] [Full Text] [Related]

  • 2. Strength in numbers or antitrust trouble?
    Bianculli JL.
    Contemp Longterm Care; 1997 May; 20(5):60-1. PubMed ID: 10167546
    [No Abstract] [Full Text] [Related]

  • 3. Powerful networks could result in public utility-style regulation of health care.
    Weil TP.
    Healthspan; 1995 Feb; 12(2):12-5. PubMed ID: 10166119
    [No Abstract] [Full Text] [Related]

  • 4. The legal framework for effective competition.
    Berenson RA, Hastings DA, Kopit WG.
    Baxter Health Policy Rev; 1996 Feb; 2():235-65. PubMed ID: 11066262
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A practical approach for analyzing antitrust issues faced by provider networks.
    Ross DC.
    J Health Hosp Law; 1997 Feb; 30(3):133-45. PubMed ID: 10179111
    [No Abstract] [Full Text] [Related]

  • 7. Increasing consolidation in healthcare markets: what are the antitrust policy implications?
    Haas-Wilson D, Gaynor M.
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1403-19. PubMed ID: 9865226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. What's in store for physicians when a market enters Phase III.
    Caesar N.
    Manag Care; 1996 Jan; 5(1):47-8. PubMed ID: 10155839
    [No Abstract] [Full Text] [Related]

  • 10. Capitation revisited: integrated systems learn how to manage care and risk.
    Tokarski C.
    Health Syst Lead; 1995 Apr; 2(3):4-11. PubMed ID: 10154246
    [Abstract] [Full Text] [Related]

  • 11. Antitrust and the developing continuum: advice for administrators, managers, and providers.
    Garrison P.
    Continuum; 1998 Apr; 18(1):1, 3-6. PubMed ID: 10178903
    [No Abstract] [Full Text] [Related]

  • 12. The fraud and abuse statute in an evolving health care marketplace: life in the health care speakeasy.
    Blumstein JF.
    Am J Law Med; 1996 Apr; 22(2-3):205-31. PubMed ID: 8862242
    [No Abstract] [Full Text] [Related]

  • 13. Limits placed on PHOs by antitrust rulings, transitional structure for integration.
    Health Care Strateg Manage; 1995 Nov; 13(11):14-5. PubMed ID: 10151858
    [No Abstract] [Full Text] [Related]

  • 14. Managed competition, integrated delivery systems and antitrust.
    Greaney TL.
    Cornell Law Rev; 1994 Sep; 79(6):1507-45. PubMed ID: 10141442
    [No Abstract] [Full Text] [Related]

  • 15. Avoid the antitrust trap: providers must study the law before they partner.
    Litwak P.
    Behav Healthc Tomorrow; 1999 Aug; 8(4):19-23. PubMed ID: 10557691
    [No Abstract] [Full Text] [Related]

  • 16. Integration options.
    Williams L.
    J Health Hosp Law; 1996 Aug; 29(2):88-96, 106. PubMed ID: 10160177
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Avoiding antitrust snags requires forethought and thorough market analysis.
    Engstrom P.
    Med Netw Strategy Rep; 1995 May; 4(5):1-4. PubMed ID: 10153138
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.